Sugentech Inc. (KOSDAQ:253840)
4,500.00
-115.00 (-2.49%)
Sep 21, 2026, 3:30 PM KST
Sugentech Revenue
Sugentech had revenue of 3.08B KRW in the quarter ending June 30, 2026, a decrease of -2.82%. This brings the company's revenue in the last twelve months to 9.78B, down -15.96% year-over-year. In the year 2025, Sugentech had annual revenue of 9.42B, down -6.74%.
Revenue (ttm)
9.78B
Revenue Growth
-15.96%
P/S Ratio
7.03
Revenue / Employee
67.95M
Employees
144
Market Cap
68.80B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.42B | -680.23M | -6.74% |
| Dec 31, 2024 | 10.10B | 2.96B | 41.57% |
| Dec 31, 2023 | 7.13B | -94.27B | -92.97% |
| Dec 31, 2022 | 101.40B | 24.20B | 31.34% |
| Dec 31, 2021 | 77.20B | 35.85B | 86.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DRTECH | 126.23B |
| Dongbang Medical | 125.12B |
| Ray Co., Ltd. | 119.17B |
| Osang Healthcare Co.,Ltd | 96.48B |
| T&R Biofab | 32.73B |
| Humasis | 31.73B |
| Access Bio | 23.54B |
| P&S Robotics | 8.55B |